Perhaps the most important long-term bladder cancer data #ASCO24 Neoadjuvant Toripalimab & disitimab Vedotin in muscle invasive bladder cancer (n=47). pCR ⬆️ 63%. 14% G3/4 AEs. All surgeries occurred . The 1st MMAE/IO neoadjuvant combo data looks ✅✅. EV/IO MIBC trials awaited

Characterization of complete responders to nivolumab + gemcitabine-cisplatin vs gemcitabine-cisplatin alone and patients with lymph node–only metastatic #UrothelialCarcinoma from #CheckMate 901. Presented by Matt Galsky. #ASCO24 written coverage > bit.ly/3VtnrVz

The IBCG Quick Guide to Non-Muscle Invasive Bladder Cancer (NMIBC) Bladder Cancer Quick Reference Sheet summarizes essential details on diagnosis, treatment options, and follow-up for NMIBC all in one convenient place #AUA24 #EAU24 #IBCG24 #ASCO24 Designed by Amanda Myers

We are very excited to introduce you to our new Board members. Today was our first meeting and their enthusiasm was extremely motivating! The future is so bright ✨ Keep an eye on us!

🧐Interested in how #NMIBC could be managed in the future? Look at our algorithm for IR-NMIBC! 🕵🏼‍♂️Thorough review of new alternatives in EVERY STAGE of NMIBC 📰Out in European Urology Oncology 👓Read it: t.ly/EpX-n 👥Ashish M. Kamat, MD, MBBS Sia Daneshmand, M.D. Antoni Vilaseca Morgan Roupret Shahrokh F. Shariat

´#EDI committee is mandatory for any organisation’ reminded European Association of Urology (EAU) European Association of Urology today. Association Française d'Urologie - AFU is also moving in this correct direction! AFUF

📹 Check out the recommendations (& a new chapter!) in the latest #eauguidelines on #NMIBC. Our BCa chief editor Dr. Benjamin Pradere & Prof. Paolo Gontero discuss crucial updates on substaging, treatment options, follow-up, biomarkers & more! 👇 bladder.uroonco.uroweb.org/video/eau-guid…

Clinical Validation of the Intermediate-risk NMIBC Scoring System and Substratification Model Proposed by the IBCG (International Bladder Cancer Group): A Multicenter YAU Urothelial Working Group Collaboration European Urology Oncology Paolo Gontero francesco soria authors.elsevier.com/c/1jIAG9Cfv--d… a🧵

Ashish M. Kamat, MD, MBBS European Urology Oncology Paolo Gontero Jeremy Teoh Benjamin Pradere Laura S. Mertens Marco Moschini Shahrokh F. Shariat Ekaterina Laukhtina IBCG Roger Li Andrea Necchi Max Kates EAU Edu Platform UROONCO Sia Daneshmand, M.D. Joan Palou Redorta Gary Steinberg Philippe spiess Peter Black Wes Kassouf Rob Svatek Félix Guerrero-Ramos Petros Grivas Matt Galsky Marek Babjuk Morgan Roupret Maria J. Ribal Dave Penson Sam S. Chang MD, MBA Laura Bukavina Kelly Bree Evanguelos Xylinas evacomperat Thank you Ashish M. Kamat, MD, MBBS and thank to all the EAU YAU Urothelial Carcinoma group. Great team effort!

Finally released! Huge kudos to Laura S. Mertens, Max Bruins and the #EAU NMIBC and MIBC guidelines panel for creating a practical follow-up framework for #bladdercancer patients after RC Link ➡️ authors.elsevier.com/c/1jIOc_wtO--z… European Association of Urology (EAU) European Urology Oncology

Roberto Contieri Laura S. Mertens European Association of Urology (EAU) European Urology Oncology Paolo Gontero francesco soria Morgan Roupret Prof Param Mariappan Benjamin Pradere Evanguelos Xylinas UroToday.com Very important guidelines for all of us taking care of bladder cancer patients, congratulations!

Very nice lecture by Benjamin Pradere about #overtreatment and #oversurveillance for low-grade #NMIBC, talking about how to de-intensify. #UROonco24

Buongiorno da @oltredna 🇮🇹 - 🧵 Il nostro obiettivo è la prevenzione e la diagnosi precoce grazie alla medicina personalizzata. Contribuiamo ad un futuro nel quale la diagnosi precoce e la personalizzazione delle cure siano realtà.

Positive results from the NIAGARA Phase III trial showed durvalumab with neoadjuvant chemo then cystectomy had a statistically significant and clinically meaningful improvement in EFS & OS versus chemo/cystectomy alone in muscle invasive bladder cancer astrazeneca.com/media-centre/p…

Don’t miss this challenging session with Benjamin Pradere Morgan Roupret Vedang Murthy Evanguelos Xylinas Wes Kassouf Vérane Achard Bladou Franck Jb Beauval Pignot Géraldine Ploussard Guillaume Pouessel Damien Roubaud Guilhem MathieuRoumiguié Paul Sargos #focusmeeting #urology #oncology #radiotherapy

Phase 3 NIAGARA Trial of Durvalumab/Chemo Shows Enhanced Survival in MIBC targetedonc.com/view/phase-3-n… @targetedonc Tom Powles Petros Grivas

Happy to share the link to the newly released summary of the NMIBC EAU guidelines! kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2… Thanks to European Association of Urology (EAU) EAU guidelines Maria J. Ribal for support and to Alex Masson-Lecomte Emma Jane Smith Prof Param Mariappan Shahrokh F. Shariat for the outstanding work!

IBCG24 has officially concluded, and what an inspiring event it was! The passion, dedication, and collaboration on display were truly remarkable. A huge thank you to all the participants, especially our patient advocates, whose valuable insights and unwavering commitment to